B9EBG0 AF NFT

Polyribonucleotide nucleotidyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaaay775n5nefntvavy2jbn5yuzdrcrzvt2nf4iiyftldmyferee4/metadata.json
IPFS of structure file: 
bafybeicpmsv6cxkracwmlivqv6nagsrqd3ywwt3pp7jrfbiufr2be3khzy/AF-B9EBG0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x67Cfa51D47d3aEF6be80EF3a7dDDb43e89bf6Ade
First NFT owner address (bech32): 
genesis1vl8628286wh0d05qaua8mhd586ym76k7rz6qdg
Current NFT ID #304337 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
304337
Accession (UniProt):
B9EBG0
Name::
Polyribonucleotide nucleotidyltransferase
Experimental Method:
Predicted structure
Sequence source:
Macrococcus caseolyticus (strain JCSC5402)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B9EBG0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B9EBG0|PNP_MACCJ Polyribonucleotide nucleotidyltransferase OS=Macrococcus caseolyticus (strain JCSC5402) OX=458233 GN=pnp PE=3 SV=1 MSQEKKVFKTEWAGRPLIIETGQLAKQANGAVLVRYGDTVVLSTATASKEPRDVDFFPLMVNYEEKLYAAGKIPGGFNKREGRPGEDATLTSRLIDRPIRPLFPKGYRHDVQVISIVMSVDPDNSPEMAAMIGSSMALAVSDIPFEGPIAGVNVGLVDGELIINPDVQQREVSVLDLQVAGHFDAVNMVEAGAKEVAEDKMLEAIMFGHAEIKKLVEFQQSIIDEIQPVKSEFVPVEVDADLESKVEQLSESFGLSQAIQTQEKLAREENITAIKLKVIEAFEGEDEAVITAVNKKFDALIKEEVRRLITEEKVRPDGRRPDEIRPLDSEVGILPRVHGSGLFTRGQTQALSVATLGALGEHQIIDGLGVEEEKRYMHHYNFPNFSVGETGPIRAPGRREIGHGALGERALLQVIPDEKEFPYTIRVVSEVLESNGSSSQASICGSTLALMDAGVPIKAPVAGIAMGLVTKDENYTILSDIQGMEDALGDMDFKVAGTKEGITAIQMDIKINGLTEDILREALEQARVGRLHIMEHMLSTISEPRAELSQYAPKIEIIHINPDKIRDVIGPGGKKINEIIDATGVKLDIEQDGTVFIGSSDASMIEAAKKLIENIVREAEVGQIYMATVKRIEKFGAFVEIFPGKDALVHISQIALERINKVEDVVKLGDQFLVKVTEIDKQGRVNASRKVLLEEEKKASEEK